Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

​​ Tardive dyskinesia (TD) is a condition of potentially irreversible abnormal involuntary movements associated with dopamine receptor blocking agents, such as antipsychotics. While prevention is the best strategy, it is not always possible. This report outlines strategies to reduce TD symptoms, including the use of the FDA-approved treatment options (valbenazine and deutetrabenazine). © Copyright 2020 Physicians Postgraduate Press, Inc.


Joseph P McEvoy. Selecting Treatment for Patients With Tardive Dyskinesia Using Safety and Efficacy Evidence. The Journal of clinical psychiatry. 2020 Sep 29;81(6)

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 32991793

View Full Text